Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP349341.RAaKcP4rDwkC6kFH5lc8JWGXBLzkPdM59IUa2A8ViQ80g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP349341.RAaKcP4rDwkC6kFH5lc8JWGXBLzkPdM59IUa2A8ViQ80g130_assertion type Assertion NP349341.RAaKcP4rDwkC6kFH5lc8JWGXBLzkPdM59IUa2A8ViQ80g130_head.
- NP349341.RAaKcP4rDwkC6kFH5lc8JWGXBLzkPdM59IUa2A8ViQ80g130_assertion description "[The goal of this pilot study was to assess the feasibility of in vivo phenotyping of CYP2D6 in an elderly population with dementia and to determine if part of the variability in response to treatment with galantamine is attributable to CYP2D6 phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349341.RAaKcP4rDwkC6kFH5lc8JWGXBLzkPdM59IUa2A8ViQ80g130_provenance.
- NP349341.RAaKcP4rDwkC6kFH5lc8JWGXBLzkPdM59IUa2A8ViQ80g130_assertion evidence source_evidence_literature NP349341.RAaKcP4rDwkC6kFH5lc8JWGXBLzkPdM59IUa2A8ViQ80g130_provenance.
- NP349341.RAaKcP4rDwkC6kFH5lc8JWGXBLzkPdM59IUa2A8ViQ80g130_assertion SIO_000772 21803659 NP349341.RAaKcP4rDwkC6kFH5lc8JWGXBLzkPdM59IUa2A8ViQ80g130_provenance.
- NP349341.RAaKcP4rDwkC6kFH5lc8JWGXBLzkPdM59IUa2A8ViQ80g130_assertion wasDerivedFrom befree-20140225 NP349341.RAaKcP4rDwkC6kFH5lc8JWGXBLzkPdM59IUa2A8ViQ80g130_provenance.
- NP349341.RAaKcP4rDwkC6kFH5lc8JWGXBLzkPdM59IUa2A8ViQ80g130_assertion wasGeneratedBy ECO_0000203 NP349341.RAaKcP4rDwkC6kFH5lc8JWGXBLzkPdM59IUa2A8ViQ80g130_provenance.